PORT | ENG

About us

ADAVIUM Medical is a US venture capital-backed company created to be the largest medical equipment and diagnostics company focused on Brazil, the third largest private healthcare market in the world. The Company was formed with the intent to bring commercial sophistication to a highly fragmented market, partnering with some of the most innovative companies in the world, and developing and commercializing complementary high-quality, yet cost-effective, products that we develop on our own for the value-based – or “long tail” –
segment of the market in Brazil and in other emerging markets.

When many in the medical device and diagnostics industry think about Brazil, what commonly comes to mind is a large vibrant market, but with complex regulatory requirements, loose standards, limited commercial sophistication and a high cost of capital. By navigating this complexity, we have built a commercial leader in Brazil.

Adavium Medical was formed with the intent to commercialize the most innovative portfolio of medical device and diagnostics products in Brazil. Our portfolio today is made up of products that we commercialize on behalf of leading international companies from around the World.

We have assembled an experienced team of more than 300 employees that ensure that our fully-integrated commercial platform operates at world-class standards.

We have chosen to specialize in two segments that we can “own”:
• Medical devices, focused on aesthetics, dermatology, plastic surgery, vascular surgery and
gynecology
• Clinical diagnostics, focused on equipment and reagents used by clinical laboratories

Both markets are $1 billion markets individually, with substantial growth potential driven by demographics and the growing privatization of healthcare.

We have the largest customer base across premium and “long tail” customers of any medical equipment and/or diagnostics company in Brazil, with more than 2,500 customers respectively in medical equipment and diagnostics. This is exponentially more than the average distributor or multinational in the region.

ABOUTUS_01_C

The Expert in Brazil’s Medical Device and Diagnostics Industry


We understand Brazil from a sophisticated, comprehensive perspective and have very experienced leaders from multinationals in Brazil that understand how to navigate this challenging environment. Our team takes a world-class approach to regulatory, quality, manufacturing, compliance, ethics, customer relationship management and financing, applying discipline to an undisciplined region.

In short, we make the process of commercializing medical technology in Brazil easy for our partners.

We collaborate with ANVISA to ensure fast regulatory approvals, work to ISO manufacturing and distribution standards, are compliant with Department of Justice anti-corruption standards (FCPA) and utilize world-class auditors for the highest levels of financial compliance.

With Brazil’s population of 200 million growing rapidly and with a private healthcare market larger than any other country in the world except the US and China, our partners cannot afford to bypass the region, or to fail.

ABOUTUS_02

A Product Engine for Value Products


In addition to our leading capabilities to commercialize premium products in Brazil, we also offer products that meet the needs of the “long tail” of the market – customers in this segment value high-quality, yet more affordable options, and are typically neglected. Our R&D activities are focused on developing affordable solutions for customers with unmet needs and manufacturing them in our state-of-the-art, ISO-certified facilities. Many of our proprietary products have leading market share positions in Brazil.

ABOUTUS_03

The Future


We intend to continue consolidating our leadership position in the medical equipment and diagnostic sectors by:
• expanding our commercial partnerships with leading international companies
• developing proprietary, complementary products for markets in Brazil and other emerging economies
• opportunistically acquiring medical device and diagnostics businesses to enhance our commercial capabilities and product portfolio

Our ultimate goal is to bring our unique expertise to emerging markets globally.

Leadership

Fred Aslan, MD, – CEO and Founder

fred Born and raised in Brazil, Dr. Fred Aslan is the founder of Adavium Medical (previously known as ADVANCE Medical). He is also affiliated with Venrock, a leading Silicon Valley venture capital firm he joined in 2006. While a full-time investor at Venrock prior to founding Adavium, Dr. Aslan was a co-founder and board member of Receptos Pharmaceuticals, a NASDAQ-listed biotech company, which was subsequently acquired by Celgene for more than $8 billion. He also led Venrock’s investment in Zeltiq, a NASDAQ-listed medical device company that was valued at more than $1 billion. Prior to Venrock, he was Director of Business Development and led Investor Relations at CuraGen, a NASDAQ-listed oncology-focused biotech company, and was a strategy consultant with Boston Consulting Group (BCG). He was named the “2014 Business Professional of the Year” by the Brazilian government, recognizing the achievements of Brazilian professionals living outside of Brazil. He is also a board member of Femasys, a US-based women’s health medical device company, and BayBrazil, a Silicon Valley-based not-for-profit organization promoting ties between Silicon Valley and Brazil. Dr. Aslan received a B.S. in Biology from Duke University, an M.D. from Yale and an M.B.A. from Harvard.

Andre Tanaka - President, Vydence Medical

Andre was President of Industra Technologies prior to its merger with Adavium Medical’s dermatology device division to form Vydence Medical, the largest Brazilian company focused on the sales of energy-based devices to dermatologists  and other specialties. Prior to the transaction with Adavium, Andre led Industra to become one of the leading companies in the segment – he was responsible for the development and commercialization of multiple laser-based devices which are today market share leaders in Brazil. Andre is a mechanical engineer by training.

 

Stenio Alvarenga - President, Vyttra Diagnosticos

Stenio joined Adavium Medical as President of Vyttra in 2018. He is one of the lab-to-lab pioneering executives in Brazil. Reporting to the CEO of DASA, Stenio led DASA’s lab-to-lab business from 2010 to 2015 managing a sales force of over 100 sales people calling on laboratories of different sizes throughout Brazil. Most recently, Stenio was VP Comercial in charge of Brazil, Portugal and Spain for CERBA International, a leading reference lab. Stenio started his career in a variety of executive roles at large companies including AMBEV, TIM and Kirin. Stenio graduated in business administration with subsequent post-grad training in master degree programs.

 

Edmar Paiva - CFO, Adavium Medical

Edmar joined Adavium Medical in 2017 as CFO. Prior to Adavium Medical, Edmar was Executive Director and Controller at Localiza-Hertz, Brazil’s largest rental car company, with one of the World’s largest market caps for a rental car company. Edmar joined Localiza in 2007 and rose through the ranks over a decade-long career. In his last role at Localiza, Edmar was responsible for the integration of Hertz Brazil operations, recently acquired by Localiza. Prior to Localiza, Edmar held a number of finance roles and started his career in auditing at Coopers and Lybrand.

 

Board

Select below a name to see more info.

Fred Aslan, MD, – CEO and Founder

Born and raised in Brazil, Dr. Fred Aslan is the founder of Adavium Medical (previously known as ADVANCE Medical). He is also affiliated with Venrock, a leading Silicon Valley venture capital firm he joined in 2006. While a full-time investor at Venrock prior to founding Adavium, Dr. Aslan was a co-founder and board member of Receptos Pharmaceuticals, a NASDAQ-listed biotech company, which was subsequently acquired by Celgene for more than $8 billion. He also led Venrock’s investment in Zeltiq, a NASDAQ-listed medical device company that was valued at more than $1 billion. Prior to Venrock, he was Director of Business Development and led Investor Relations at CuraGen, a NASDAQ-listed oncology-focused biotech company, and was a strategy consultant with Boston Consulting Group (BCG). He was named the “2014 Business Professional of the Year” by the Brazilian government, recognizing the achievements of Brazilian professionals living outside of Brazil. He is also a board member of Femasys, a US-based women’s health medical device company, and BayBrazil, a Silicon Valley-based not-for-profit organization promoting ties between Silicon Valley and Brazil. Dr. Aslan received a B.S. in Biology from Duke University, an M.D. from Yale and an M.B.A. from Harvard.

Claudia Goulart - Former CEO of GE HealthCare Latin America

Claudia Goulart has served as a board member of Adavium Medical since 2013 and as President of Vyttra Diagnosticos from early 2016 to early 2018. Previously, she served as the CEO of GE Healthcare for Latin America from 2003 to 2011. Prior to GE Healthcare, she held senior leadership roles in a number of private equity-backed companies, including serving as Chief Financial Officer at IG (Internet Group do Brasil) and Ferrovia Centro Atlantica. Ms. Goulart presently sits on the board of directors of Pixeon and ToLife. She has a Bachelors Degree in Business/ Managerial Economics from the Universidade Federal de Minas Gerais and a Masters in Applied Psychology from CEMPE. Brazil’s leading business publication – Valor Economico – has named her one of its “Top Female Executives 2011.”

Darren Hite - Aberdare Ventures

Mr. Hite is as Partner at Aberdare Ventures, a venture capital firm he joined in 2006. Darren focuses on investments addressing key inefficiencies in large healthcare markets. More recently, Darren has led Aberdare’s investment efforts in healthcare technology companies outside of the US. Darren serves on the board of goBalto, Jiff, and RxAnte, and is the Director of Special Projects at mc10. He was a founding investor in Rock Health and is a mentor for early stage healthcare technology companies through his involvement with Rock Health, Blueprint Health, UCSF, and Stanford. Prior to Aberdare, Darren was a corporate strategy associate at Medtronic and an investment banking analyst at Robertson Stephens. Darren attended the MD program at Georgetown University School of Medicine and the Biodesign program at Stanford University. He holds an A.B. in Evolutionary Biology from Princeton University and an MBA from the Stanford Graduate School of Business.

Paul McCreadie - Arboretum Ventures

Mr. McCreadie is a Managing Director of Arboretum Ventures, a venture capital firm he joined in 2006. He invests in capital-efficient medical technology, service, and health IT companies focusing on the application of innovative technologies to underserved markets. Paul serves on the board of ArborMetrix, Delphinus Medical Technologies and Wellfount, and is the former Chief Operating Officer for CerviLenz, an Arboretum portfolio company based in Ohio. Prior to joining Arboretum, Mr. McCredie worked at Ford Motor Company for eight years, holding management positions within new product development, manufacturing, and business strategy. He was an associate with the Wolverine Venture Fund (WVF) while an M.B.A. student at Michigan’s Ross School of Business.

Bryan Roberts, Ph.D. - Venrock

Dr. Roberts is a Partner at Venrock, a venture capital firm he joined in 1997. At Venrock, he has invested broadly in healthcare technology including therapeutics, medical devices, and diagnostic companies. Dr. Roberts is Chairman of Ironwood Pharmaceuticals and serves on the board of over a dozen other healthcare technology companies. He has been ranked the #1 healthcare investor by Forbes magazine since 2008 and is a Henry Crown Fellow. Dr. Roberts received a B.A. from Dartmouth College and a Ph.D. in chemistry and chemical biology from Harvard University.

Omar Hauache, M.D. – former Chairman and CEO of Glupo Fleury

Dr. Hauache is the former CEO and Chairman of the Board of Grupo Fleury, one of the largest, and most prestigious clinical laboratory groups in Brazil. He joined Grupo Fleury in 2000 as a practicing physician and grew his responsibilities during his 15 year career in the organization. Dr. Hauache was trained as an endocrinologist in Brazil and did his molecular endocrinology postdoctoral fellowship at the National Institutes of Health (NIH) in Bethesda, MD.

Investors

logo1logo2logo3logo-cliente

This is a unique website which will require a more modern browser to work! Please upgrade today!

TOP